This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barthel, A. Articles by Joost, H.-G. Search for Related Content PubMed PubMed Citation Articles by Barthel, A. Articles by Joost, H.-G.

Regulation of the Forkhead Transcription Factor FKHR (FOXO1a) by Glucose Starvation and AICAR, an Activator of AMP-Activated Protein Kinase

Institut für Pharmakologie und Toxikologie, RWTH Aachen, D-52057 Aachen, Germany (A.G., K.D.K.), Abteilung Biochemie, Universität Greifswald, D-17487 Greifswald, Germany (D.S.) German Institute of Human Nutrition, D-14558 Potsdam-Rehbrücke, Germany (H.-G.J.), and Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, California 94305 (R.A.R.)

Abstract

Expression of the catalytic subunit of glucose-6-phosphatase (G6Pase) has recently been shown to be transactivated by the transcription factor FKHR. Insulin and conditions of energy depletion are known repressors of the G6Pase gene. Whereas insulin is known to inhibit G6Pase expression by phosphorylation and nuclear exclusion of FKHR, the mechanism of repression of G6Pase by energy depletion is unknown. Here, we have studied the effect of glucose starvation and AICAR, an activator of AMP-activated protein kinase (AMPK) on G6Pase expression and the expressional level of FKHR-protein in hepatic cells. Using a H4-hepatoma cell line stably overexpressing FKHR, we found that both glucose starvation and treatment of cells with AICAR strongly repressed G6Pase expression and led to an almost complete disappearance of the FKHR protein, whereas the levels of control proteins and FKHR mRNA were not affected. Our data suggest that AICAR and glucose starvation inhibit G6Pase expression by a reduction of the cellular level of FKHR, presumably mediated by specific degradation of the protein.

This article has been cited by other articles:

				D. Chanda, S.-J. Kim, I.-K. Lee, M. Shong, and H.-S. Choi Sodium arsenite induces orphan nuclear receptor SHP gene expression via AMP-activated protein kinase to inhibit gluconeogenic enzyme gene expression Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E368 - E379. [Abstract] [Full Text] [PDF]

				Y. D. Kim, K.-G. Park, Y.-S. Lee, Y.-Y. Park, D.-K. Kim, B. Nedumaran, W. G. Jang, W.-J. Cho, J. Ha, I.-K. Lee, et al. Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase-Dependent Regulation of the Orphan Nuclear Receptor SHP Diabetes, February 1, 2008; 57(2): 306 - 314. [Abstract] [Full Text] [PDF]

				P. Philip-Couderc, N. I. Tavares, A. Roatti, R. Lerch, C. Montessuit, and A. J. Baertschi Forkhead Transcription Factors Coordinate Expression of Myocardial KATP Channel Subunits and Energy Metabolism Circ. Res., February 1, 2008; 102(2): e20 - e35. [Abstract] [Full Text] [PDF]

				M. Dixit, E. Bess, B. Fisslthaler, F. V. Hartel, T. Noll, R. Busse, and I. Fleming Shear stress-induced activation of the AMP-activated protein kinase regulates FoxO1a and angiopoietin-2 in endothelial cells Cardiovasc Res, January 1, 2008; 77(1): 160 - 168. [Abstract] [Full Text] [PDF]

				E. L. Greer, P. R. Oskoui, M. R. Banko, J. M. Maniar, M. P. Gygi, S. P. Gygi, and A. Brunet The Energy Sensor AMP-activated Protein Kinase Directly Regulates the Mammalian FOXO3 Transcription Factor J. Biol. Chem., October 12, 2007; 282(41): 30107 - 30119. [Abstract] [Full Text] [PDF]

				A. Kantarci, P. Augustin, E. Firatli, M.C. Sheff, H. Hasturk, D.T. Graves, and P.C. Trackman Apoptosis in Gingival Overgrowth Tissues J. Dent. Res., September 1, 2007; 86(9): 888 - 892. [Abstract] [Full Text] [PDF]

				A. Kantarci, P. Augustin, E. Firatli, M.C. Sheff, H. Hasturk, D.T. Graves, and P.C. Trackman Apoptosis in Gingival Overgrowth Tissues Journal of Dental Research, September 1, 2007; 86(9): 888 - 892. [Abstract] [Full Text] [PDF]

				D. A Glauser and W. Schlegel The emerging role of FOXO transcription factors in pancreatic {beta} cells J. Endocrinol., May 1, 2007; 193(2): 195 - 207. [Abstract] [Full Text] [PDF]

				B. Fisslthaler, I. Fleming, B. Keseru, K. Walsh, and R. Busse Fluid Shear Stress and NO Decrease the Activity of the Hydroxy-Methylglutaryl Coenzyme A Reductase in Endothelial Cells via the AMP-Activated Protein Kinase and FoxO1 Circ. Res., February 2, 2007; 100(2): e12 - e21. [Abstract] [Full Text] [PDF]

				D. Freyssenet Energy sensing and regulation of gene expression in skeletal muscle J Appl Physiol, February 1, 2007; 102(2): 529 - 540. [Abstract] [Full Text] [PDF]

				B. Viollet, M. Foretz, B. Guigas, S. Horman, R. Dentin, L. Bertrand, L. Hue, and F. Andreelli Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders J. Physiol., July 1, 2006; 574(1): 41 - 53. [Abstract] [Full Text] [PDF]

				J. B. Morris, B. Kenney, H. Huynh, and E. A. Woodcock Regulation of the Proapoptotic Factor FOXO1 (FKHR) in Cardiomyocytes by Growth Factors and {alpha}1-Adrenergic Agonists Endocrinology, October 1, 2005; 146(10): 4370 - 4376. [Abstract] [Full Text] [PDF]

				A. Barthel and D. Schmoll Novel concepts in insulin regulation of hepatic gluconeogenesis Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E685 - E692. [Abstract] [Full Text] [PDF]

				W. Wang, X. Yang, I. Lopez de Silanes, D. Carling, and M. Gorospe Increased AMP:ATP Ratio and AMP-activated Protein Kinase Activity during Cellular Senescence Linked to Reduced HuR Function J. Biol. Chem., July 11, 2003; 278(29): 27016 - 27023. [Abstract] [Full Text] [PDF]